cardiac pain; cardiac disorder; fever chills; application site pain; headache; myalgia; arthralgia; fatigue; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: at-basgages-2021-064479 (ra). a 31 year-old female patient received bnt162b2 (comirnaty), administration date 22jul2021 (lot number: unknown) at the age of 31 years as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: covid-19 vaccine (dose 1, manufacturer unk), for covid-19 immunization. the following information was reported: angina pectoris (medically significant) with onset 22jul2021, outcome "recovered", described as "cardiac pain"; cardiac disorder (non-serious) with onset 22jul2021, outcome "recovered", described as "cardiac disorder"; pyrexia (non-serious) with onset 22jul2021, outcome "recovered", described as "fever chills"; vaccination site pain (non-serious) with onset 22jul2021, outcome "recovered", described as "application site pain"; headache (non-serious) with onset 22jul2021, outcome "recovered", described as "headache"; myalgia (non-serious) with onset 22jul2021, outcome "recovered", described as "myalgia"; arthralgia (non-serious) with onset 22jul2021, outcome "recovered", described as "arthralgia"; fatigue (non-serious) with onset 22jul2021, outcome "recovered", described as "fatigue". no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected